Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Smartphone CBT‑I app for insomnia in cancer survivors

Official title: iCANSleep: A Randomized Controlled Trial of a Smartphone App-Based Insomnia Treatment for Cancer Survivors

Run by Memorial University of Newfoundland · NCT07101302 · Data updated 2026-11-12

This project will test whether the iCANSleep smartphone app reduces insomnia symptoms in Canadian adults who have completed cancer treatment.

More Insomnia trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment146 (estimated)
SponsorMemorial University of Newfoundland
Academic / other
Drugs / interventionschemotherapy, immunotherapy
Locations1 site (St. John's, Newfoundland and Labrador)
StatusRecruiting
StartedNovember 4, 2025
Main results expectedNovember 2026
Study endsNovember 2026
Registry record updatedFebruary 20, 2026
Trial IDNCT07101302 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (≥18) living in Canada who are cancer survivors with DSM‑5 insomnia and ISI ≥8, completed or stabilized treatment for at least 3 months, have ECOG 0–2, are fluent in English or French, and own and can use a smartphone with internet.

Probably not a fit

People currently undergoing active cancer treatment, those without smartphone/internet access or app skills, or those with uncontrolled severe medical or psychiatric conditions or without DSM‑5 insomnia are unlikely to benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Researchers will randomize 146 Canadian adult cancer survivors meeting DSM‑5 criteria for insomnia to immediate access to a seven‑module CBT‑I app (iCANSleep) or to an 8‑week waitlist with delayed access. The immediate group completes the modules right away while the delayed group begins after the wait period; both groups complete assessments at baseline, mid‑treatment, post‑treatment, and at 3‑month follow‑up (the delayed group has extra assessments during the wait). The primary outcome is change in Insomnia Severity Index (ISI); secondary measures include fatigue, anxiety, depression, pain, work productivity, sleep beliefs, daytime impact, and pre‑sleep arousal. Eligibility requires adults living in Canada who are fluent in English or French, own a smartphone with internet access, and meet performance and stability/remission criteria to ensure insomnia is not an acute response to treatment.

Why it matters

Potential benefit: If effective, the app could offer an accessible at‑home CBT‑I option that lowers insomnia severity and related symptoms for cancer survivors.

How similar studies have gone: Therapist‑delivered and digital CBT‑I have previously reduced insomnia, including evidence in cancer survivor populations, so this app builds on established methods rather than being entirely untested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Cancer survivors
* Over 18 years of age
* Lives in Canada
* Understands English or French fluently
* DSM-5 diagnosis of insomnia
* ISI score of 8 or higher
* Good performance status as indicated by a score of 0-2 on the Eastern Cooperative Oncology Group (ECOG) performance status scale
* Access to internet connection
* Ownership of smartphone
* Fluency using mobile applications.
* Individuals with non-hematological malignancies must show no evidence of cancer or clinically stable/inactive disease for a minimum of 3 months prior to enrollment (for individuals with non-metastatic cancer) or be on a stable treatment regimen for the prior 3 months (for individuals with metastatic cancer) to ensure that insomnia is not a direct, acute response to cancer treatment.
* Individuals with hematological malignancies must be in remission at the time of recruitment and have completed cancer treatments (e.g., transplant, chemotherapy, immunotherapy, radiotherapy) at least 3 months prior.

Exclusion Criteria:

* Presence of a sleep disorder other than insomnia that is not adequately treated (e.g., untreated sleep apnea)
* Presence of a psychological disorder that is currently untreated or would impair the ability to participate (e.g., bipolar disorder)
* Major sensory deficit (e.g., blindness)
* Previous experience receiving CBT-I.
* The use of medications prescribed for sleep (e.g., hypnotics, sedatives, or antidepressants) will be tracked and adjusted for in the statistical analysis.

Where it's running

  • Memorial University of Newfoundland
    St. John's, Newfoundland and Labrador, Canada
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.